Related Experiment Video
Updated: Jul 6, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
Ehlers-Danlos syndrome--a historical review
Liakat A Parapia1, Carolyn Jackson
1Haemophilia Centre, Bradford Teaching Hospitals Foundation Trust, Bradford Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK. parapia@doctors.org.uk
Insights
Ehlers-Danlos syndrome is a group of inherited connective tissue disorders affecting collagen synthesis. Management of bleeding issues in Ehlers-Danlos syndrome has progressed slowly.
Area of Science:
- Genetics
- Connective Tissue Diseases
- Biochemistry
Background:
- Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders.
- It is characterized by abnormal collagen synthesis, impacting skin, joints, blood vessels, and organs.
- EDS is historically recognized for causing bruising and bleeding, with early descriptions dating back to Hippocrates.
Observation:
- Edvard Ehlers identified EDS as a distinct condition in 1901.
- Henri-Alexandre Danlos highlighted skin extensibility and fragility as key features in 1908.
- The genetic basis of EDS began to be understood from the 1960s onwards.
Findings:
- The Villefranche nosology, published by Beighton in 1998, provided a classification for Ehlers-Danlos syndrome.
- Abnormal collagen synthesis is a central characteristic of EDS.
- Genetic factors have been identified as underlying the condition.
Implications:
- Understanding the genetic makeup of EDS is crucial for diagnosis and potential treatments.
- Despite historical recognition, the management of bleeding complications in EDS remains a challenge.
- Further research into collagen synthesis defects may lead to improved therapeutic strategies for Ehlers-Danlos syndrome.
Abstract:
Ehlers-Danlos syndrome is an inherited heterogeneous group of connective tissue disorders, characterized by abnormal collagen synthesis, affecting skin, ligaments, joints, blood vessels and other organs. It is one of the oldest known causes of bruising and bleeding and was first described by Hipprocrates in 400 BC. Edvard Ehlers, in 1901, recognized the condition as a distinct entity. In 1908, Henri-Alexandre Danlos suggested that skin extensibility and fragility were the cardinal features of the syndrome. In 1998, Beighton published the classification of Ehlers-Danlos syndrome according to the Villefranche nosology. From the 1960s the genetic make up was identified. Management of bleeding problems associated with Ehlers-Danlos has been slow to progress.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Desmosomes
Rheumatic Heart Disease I: Introduction
Degenerative Disc Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Degenerative Disc Disease ll: Pathophysiology

